(2-methyl-1-oxo-2,3-dihydro-1H-isoindol-4-yl)boronic acid
Structure Info
- Chemspace ID
- CSSB00009853682 (In-Stock Building Blocks)
- CAS
- 2408430-35-1
- MFCD
- MFCD18205343, MFCD18205343
- IUPAC Name
- (2-methyl-1-oxo-2,3-dihydro-1H-isoindol-4-yl)boronic acid
- Mol formula
- C9H10BNO3
- Mol weight
- 191 Da
- Catalog Number(s)
- 32R0097, ArZ-UP374507, ArZ-UP502524, BBLS00009853682, BBV-39732853, CSC009853682, EN300-2697243, FCH1150056, PI2408430351, PW1604, TX01K5GH, Y1124545, ZXC147643, ZXC218157, bbls00009853682
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.51
- Heavy atoms count
- 14
- Rotatable bond count
- 1
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.22222222222222
- Polar surface area (Å)
- 61
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB00009853682
Items Overall 11 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 50 mg | 107.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 100 mg | 137.50 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 250 mg | 163.90 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 500 mg | 217.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 1 g | 327.80 | |
| J&W PharmLab, LLC. | 3 days | United States To: | 96 | 5 g | 1,097.80 | |
Description: 2-Methyl-1-oxo-2,3-dihydro-isoindole-4-boronic acid; CAS: 2408430-35-1 | ||||||
| BB4LS US | 5 days | United States To: | 96 | 50 umol | 104.78 | |
| BB4LS US | 5 days | United States To: | 96 | 100 umol | 106.72 | |
| BB4LS US | 5 days | United States To: | 96 | 200 umol | 108.66 | |
| BB4LS US | 5 days | United States To: | 96 | 300 umol | 141.08 | |
| BB4LS US | 5 days | United States To: | 96 | 500 umol | 171.11 | |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire

![Chemical structure of [2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-4-yl]boronic acid - CSSB06446546607](/st/structure/200/7a53936b7fbbf97b0f65f0677449de4f/OB%2528O%2529c1cccc2C%2528%253DO%2529N%2528Cc12%2529C1CCC%2528%253DO%2529NC1%253DO.png)
![Chemical structure of [2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]boronic acid - CSSB21224752710](/st/structure/200/f16f48e0479a3f352aa9b22504eca196/OB%2528O%2529C1%253DCC%253DCC2%253DC1C%2528%253DO%2529N%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)
![Chemical structure of 3-[1-oxo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione - CSSB03436540097](/st/structure/200/ae62ddd09f3c97dc935c0ade1a224668/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC2%253DC1CN%2528C1CCC%2528%253DO%2529NC1%253DO%2529C2%253DO.png)







